… Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in
acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted …

… Patients with acute myeloid leukemia (AML) often reach complete remission, but relapse …
the detection of molecular minimal residual disease in virtually every patient, but its clinical …

… In patients with acute lymphoblastic leukemia (ALL), monitoring of minimal residual disease
… ALL is well demonstrated; studies in adult patients also support its prognostic value. Hence, …

… In this view, measure of minimal residual disease (MRD) promises to be an efficient tool to
establish on an individual basis the patient's leukemia's susceptibility to treatment, enhancing …

… patients, relapse is thought to result from subclinical levels of residual leukemia, termed
minimal residual disease (… a patient with a high level of residual disease detected by PCR (>102 …

… Evaluation of candidate control genes for diagnosis and residual disease detection in
leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (…

… Treatment of patients with acute myeloid leukemia (AML) … strong correlations of minimal
residual disease (MRD) … evaluation by MFC at diagnosis to identify leukemia-associated aberrant …

… Assessment of measurable residual disease (MRD) after treatment can identify patients with
acute myeloid leukemia (AML) that are at high risk of poor outcomes. However, there is no …

… assay's ability to classify patients as high MRD (ie, when the number of leukemic blasts in a
… accuracy in defining patients with low MRD (ie, when the number of leukemic cells in a tissue …

… Furthermore, we have explored whether residual disease was … Patients with ≥5 × 10 −3
residual leukemic cells at the end … those with less than 5 × 10 −3 residual cells (mean, 32% ± 31…